News

Medical retinal imaging company Optos plc has delivered its first next-generation ultra-widefield retinal imaging devices (Daytona) to customers. The new devices have been scaled to accommodate smaller office spaces while providing high-resolution imaging and adding new autofluorescence capabilities.

Sightpath Medical has launched a new Web site, www.SightpathMedical.com, designed to help ophthalmic professionals learn about the company's services and locate resources.

iCo Therapeutics and JDRF, formerly the Juvenile Diabetes Research Foundation, have joined forces in a phase II clinical trial to investigate the investigational drug iCo-007 as a treatment for diabetic macular edema (DME).

During Sports Eye Safety Month in April, the American Academy of Ophthalmology, through its EyeSmart program, is reminding athletes to wear appropriate, sport-specific protective eyewear, properly fitted by an eye-care professional, to prevent a sports-related eye injury.

Prevent Blindness America (PBA) has designated April as Women's Eye Health and Safety Month.

May 1 is the nomination deadline for the New York Academy of Medicine (NYAM) Lewis Rudin Glaucoma Prize.

Former Association for Research in Vision and Ophthalmology (ARVO) Executive Director Joanne G. Angle died March 8. She was 70 and had cancer.

Both systemic and localized treatment for vision-threatening uveitis are effective in improving visual acuity and controlling uveitis and macular edema, according to results from the Multicenter Uveitis Steroid Treatment (MUST) trial as presented by Jennifer E. Thorne, MD, PhD, here at the 24th annual Current Concepts in Ophthalmology meeting.

In this quartery column in association with Ophthalmic Women Leaders, Beiting launches the series with five pearls for anyone seeking more exposure from the podium.

Paul P. Lee, MD, JD, has come full circle. After earning his undergraduate and medical degrees from the University of Michigan in the 1980s, Dr. Lee has returned as chairman of the Department of Ophthalmology and Visual Sciences and holder of the F. Bruce Fralick scholarship.

Optimizing outcomes with correct IOL calculations for combined Descemet's stripping automated endothelial keratoplasty, cataract extraction, and IOL implantation procedures can be achieved with the same techniques that are used in cataract surgery.

Ophthalmology Times was honored for Best News Coverage at the 58th annual Jesse H. Neal National Business Journalism Awards competition recognizing editorial excellence.

The FDA clearance this past February for a second-generation version of a proprietary device allows physicians to treat both eyes simultaneously for meibomian gland dysfunction and evaporative dry eye in a relatively painless in-office procedure.

Integrin peptide therapy is an emerging new class of treatment for neovascular eye diseases, such as wet age-related macular degeneration, diabetic macular edema, and macular edema due to retinal vein occlusion.

Many ophthalmologists have yet to embrace the role of "refractive" cataract surgeon by offering premium refractive IOLs to their patients.

Novel strategies have been developed to track the progression of dry age-related macular degeneration by monitoring the change in geographic atrophy and drusen using spectral-domain optical coherence tomography.

The FDA has granted IDE approval to Ocular Therapeutix to conduct a pivotal clinical trial investigating its proprietary synthetic ocular hydrogel polymer bandage for covering clear corneal incisions after cataract surgery.

The author describes a stepwise approach to assessing and addressing the ocular surface to enhance outcomes with cataract surgery.

Results from patients treated for refractory ulcers due to infectious keratitis show corneal collagen crosslinking is an effective intervention that results in rapid and complete healing.

Retina specialists who use compounded bevacizumab off-label to treat wet age-related macular degeneration are being warned that counterfeit vials of the cancer drug have turned up in oncology practices in the United States.

Interim results after 2 years of follow-up in the Ahmed Versus Baerveldt Study provide prospective evidence that aqueous drainage devices may be effective treatments for refractory glaucoma, and demonstrate the advantages and disadvantages of each.

Results from a retrospective review of outcomes after transcleral or endoscopic cyclophotocoagulation for a variety of glaucoma conditions provide additional information on the efficacy and safety of these procedures, including in select subgroups composed of eyes with either neovascular glaucoma or better than count fingers vision.

High-quality education, straight talk, and fun - those were the expressed goals that Robert H. Osher, MD, hoped to achieve during his second annual meeting, "Cataract Surgery: Telling it Like It Is!" held in January.

A hydrogel corneal inlay designed to treat presbyopia seems, based on early clinical results, to improve near vision markedly without significant safety concerns.

The annual American Society of Cataract and Refractive Surgery Symposium on Cataract, IOL, and Refractive Surgery will be held here Friday, April 20, to Tuesday, April 24.

The author tackles the issue of high levels of student loan debt.

Propanolol, a nonselective beta-blocker, is an effective treatment for infantile hemangiomas that might be used in place of steroids in selected cases.

Data from patients with the V4 model of the posterior chamber, foldable collagen copolymer phakic IOL implanted show that it provides excellent refractive and visual results, and, thanks to design modifications, a safety profile that is favorable, at least over the short term.

Advances in corneal and refractive surgery have helped optimize LASIK and transplantation procedures.

When meeting with pre-retirees as well as current retirees, one of the most common areas of concern, apprehension, and (at times) outright fear, is whether they will run out of money during retirement.